Background and rationale of platelet gel in orthopaedic surgery

被引：27

作者：

Cenni E. ^{[1
]}

Savarino L. ^{[1
]}

Perut F. ^{[1
]}

Fotia C. ^{[1
]}

Avnet S. ^{[1
]}

Sabbioni G. ^{[2
]}

机构：

[1] Laboratorio di Fisiopatologia Ortopedica e Medicina Rigenerativa, Istituto Ortopedico Rizzoli, Bologna

[2] Clinica Ortopedica e Traumatologica i, Istituto Ortopedico Rizzoli, Bologna

来源：

MUSCULOSKELETAL SURGERY | 2010年 / 94卷 / 1期

关键词：

Bone regeneration; Growth factor; Platelet gel;

D O I：

10.1007/s12306-009-0048-9

中图分类号：

学科分类号：

摘要：

Autologous platelet gel, which is usually prepared by adding thrombin and calcium to a platelet concentrate, is used to accelerate bone repair as a possible alternative to recombinant growth factors (GF), through the osteogenic GF released from a-granules. The advantages of platelet gel lie in its mimicking the GF effects of the physiological bone healing and regenerative processes, in addition to a relatively simple and low cost technique. Moreover, if autologous platelet gel is used, immunological reactions are avoided. In in vitro systems, platelet gel stimulated osteogenic differentiation of bone marrow stromal cells, while it inhibited complete osteoclast differentiation and activation. Moreover, platelet gel favoured endothelial cell proliferation and expression of pro-osteogenic functions. In experimental animals and in clinical application, the efficacy of platelet gel was increased by the combination with bone allografts, acting as scaffolds, and with bone marrow stromal cells. © Springer-Verlag 2009.

引用

页码：1 / 8

页数：7

共 52 条

[1]

Mehta S., Watson J.T., Platelet rich concentrate: Basic science and current clinical applications, J Orthop Trauma, 22, pp. 433-438, (2008)

[2]

Bianco P., Riminucci M., Gronthos S., Robey P.G., Bone marrow stromal stem cells: Nature, biology, and potential applications, Stem Cells, 19, pp. 180-192, (2001)

[3]

Davi G., Patrono C., Platelet activation and atherothrombosis, N Engl J Med, 357, pp. 2482-2494, (2007)

[4]

Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., Georgeff K.R., Platelet-rich plasma: Growth factor enhancement for bone grafts, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 85, pp. 638-646, (1998)

[5]

Marx R.E., Platelet-rich plasma: Evidence to support its use, J Oral Maxillofac Surg, 62, pp. 489-496, (2004)

[6]

Weibrich G., Hansen T., Kleis W., Buch R., Hitzler W.E., Effect of platelet concentration in platelet-rich plasma on periimplant bone regeneration, Bone, 34, pp. 665-671, (2004)

[7]

Dohan D.M., Choukroun J., Diss A., Dohan S.L., Dohan A.J., Mouhyi J., Gogly B., Platelet-rich fibrin (PRF): A second-generation platelet concentrate, Part I: Technological Concepts and Evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101, (2006)

[8]

Anitua E., Aguirre J.J., Algorta J., Ayerdi E., Cabezas A.I., Orive G., Andia I., Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers, J Biomed Mater Res B Appl Biomater, 84, pp. 415-421, (2008)

[9]

Moojen D.J., Everts P.A., Schure R.M., Overdevest E.P., Van Zundert A., Knape J.T., Castelein R.M., Creemers L.B., Dhert W.J., Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus, J Orthop Res, 26, pp. 404-410, (2008)

[10]

Everts P.A., Mahoney C.B., Hoffmann J.J., Schonberger J.P., Box H.A., Van Zundert A., Knape J.T., Platelet-rich plasma preparation using three devices: Implications for platelet activation and platelet growth factor release, Growth Factors, 24, pp. 165-171, (2006)

← 1 2 3 4 5 6 →